Physician profile
Guy B Wampler
NPI 1942232079
$8,425.08
in general payments reported to CMS, 2019-2025
13 companies · $83.48 in 2025
The $83.48 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,006 · 2020: $18.31 · 2021: $121 · 2022: $92.06 · 2023: $49.42 · 2024: $54.20 · 2025: $83.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,107.38 | 2019-2020 | |
| Nuvasive, INC. | $1,839.44 | 2019 | |
| Ethicon US, LLC | $137.94 | 2019-2025 | Echelon Flex, Surgicel Nu-Knit, Vistaseal |
| Pacira Pharmaceuticals Incorporated | $75.34 | 2021-2022 | |
| Lundbeck LLC | $54.20 | 2024 | Vyepti |
| Davol INC. | $44.17 | 2021 | |
| Merck Sharp & Dohme LLC | $30.06 | 2025 | Bridion |
| Amneal Pharmaceuticals LLC | $25.96 | 2025 | Crexont |
| Mallinckrodt Hospital Products INC. | $24.61 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.60 | 2019 | |
| Myriad Genetic Laboratories, INC. | $21.08 | 2022 | |
| Heron Therapeutics, INC. | $20.42 | 2021 | |
| Covidien Lp | $19.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Wampler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.